| pubmed-article:12791805 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0556025 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0029944 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0011892 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0027358 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0004271 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0205146 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0038951 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0181342 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0278329 | lld:lifeskim |
| pubmed-article:12791805 | lifeskim:mentions | umls-concept:C0036152 | lld:lifeskim |
| pubmed-article:12791805 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12791805 | pubmed:dateCreated | 2003-6-6 | lld:pubmed |
| pubmed-article:12791805 | pubmed:abstractText | Naloxone, an injectable opiate antagonist, can immediately reverse an opiate overdose and prevent overdose death. We sought to determine injection drug users' (IDUs) attitudes about being prescribed take-home naloxone. During November 1999 to February 2000, we surveyed 82 street-recruited IDUs from the San Francisco Bay Area of California who had experienced one or more heroin overdose events. We used a questionnaire that included structured and open-ended questions. Most respondents (89%) had witnessed an overdose, and 90% reported initially attempting lay remedies in an effort to help companions survive. Only 51% reported soliciting emergency assistance (calling 911) for the last witnessed overdose, with most hesitating due to fear of police involvement. Of IDUs surveyed, 87% were strongly in favor of participating in an overdose management training program to receive take-home naloxone and training in resuscitation techniques. Nevertheless, respondents expressed a variety of concerning attitudes. If provided naloxone, 35% predicted that they might feel comfortable using greater amounts of heroin, 62% might be less inclined to call 911 for an overdose, 30% might leave an overdose victim after naloxone resuscitation, and 46% might not be able to dissuade the victim from using heroin again to alleviate withdrawal symptoms induced by naloxone. Prescribing take-home naloxone to IDUs with training in its use and in resuscitation techniques may represent a life-saving, peer-based adjunct to accessing emergency services. Nevertheless, strategies for overcoming potential risks associated with the use of take-home naloxone would need to be emphasized in an overdose management training program. | lld:pubmed |
| pubmed-article:12791805 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12791805 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12791805 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12791805 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12791805 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12791805 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12791805 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12791805 | pubmed:issn | 1099-3460 | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:EdlinBrian... | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:KralAlex HAH | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:LorvickJennif... | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:SealKaren HKH | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:DowningMoherM | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:Singleton-Ban... | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:HammondJon-Pa... | lld:pubmed |
| pubmed-article:12791805 | pubmed:author | pubmed-author:CiccaroneDanD | lld:pubmed |
| pubmed-article:12791805 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12791805 | pubmed:volume | 80 | lld:pubmed |
| pubmed-article:12791805 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12791805 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12791805 | pubmed:pagination | 291-301 | lld:pubmed |
| pubmed-article:12791805 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:meshHeading | pubmed-meshheading:12791805... | lld:pubmed |
| pubmed-article:12791805 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12791805 | pubmed:articleTitle | Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. | lld:pubmed |
| pubmed-article:12791805 | pubmed:affiliation | Department of Family and Community Medicine, University of California, San Francisco, CA 94110, USA. karens@itsa.ucsf.edu | lld:pubmed |
| pubmed-article:12791805 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12791805 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12791805 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12791805 | lld:pubmed |
